Journal clubs offer the opportunity for 1 or 2 of the selected article’s authors to present a summary of their paper, which is then followed by a discussion and chance for participants to ask questions. Currently, journal club invitations are extended to ISPOR special interest group members and student members. Attending journal clubs are a benefit of being a member of a special interest group. To join a special interest group click here. Please contact us for more information on participating in future journal clubs.

It is advised that you read the article prior to participating in a live journal club or watching the discussion on demand.

Previously Recorded Sessions


Health Preference Research Special Interest Group


 


Title of Article: "Do Discrete Choice Experiments Approaches Perform Better Than Time Trade-Off in Eliciting Health State Utilities? Evidence From SF-6Dv2 in China"

DOI: https://doi.org/10.1016/j.jval.2020.06.010
 
Date: October 2021

Back to Top

Open Source Models Special Interest Group

Title of Article: Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy with or without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data

DOI: https://doi.org/10.1007/s40273-020-00951-1

Date: June 2022

Back to Top

Title of Article: "Cost-effectiveness of Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study"

DOI: 10.1016/j.jval.2021.06.001

Date: March 2022

Back to Top


Title of Article: “Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework“

DOI: 10.1016/j.jalz.2019.05.004

Date: November 2021

Back to Top

Title of Article: “Development and Validation of the Evaluation Platform in COPD (EPIC): A Population-Based Outcomes Model of COPD for Canada”

DOI: 10.1177/0272989X18824098

Date: March 2021

Back to Top


Health Equity Research Special Interest Group


Title of Article: "Racial, Ethnic & Socioeconomic Disparities in Curative Treatment Receipt and Survival in Hepatocellular Carcinoma"

DOI: https://aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.1002/hep4.1863  

>Date: April 2022

Back to Top

Title of Article: "Taking Into Account Patient Preferences: A Consensus Study on the Assessment of Psychological Dimensions within Patient Preference Studies "

DOI: 10.2147/PPA.S261615

Date: March 2022

Back to Top

Title of Article: “Examining equity effects of health interventions in cost-effectiveness analysis: A systematic review”

DOI: 10.1016/j.jval.2020.10.010

Date: November 2021

Back to Top


Medical Devices and Diagnostics Special Interest Group

Title of Article: "Fulfilling the Promise of Artificial Intelligence in the Health Sector: Let’s Get Real"

DOI: 10.1016/j.jval.2021.11.1369

Date: March 2022

Back to Top

Title of Article:"Using Real-World Evidence For US Payer Coverage Decision-Making"

DOI: 10.1016/j.jval.2020.02.001

Date: November 2021

Back to Top

Title of Article: “Linking the Regulatory and Reimbursement Processes for Medical Devices: The Need for Integrated Assessments”

DOI: 10.1002/hec.3479

Date: March 2021

Back to Top


Precision Medicine and Advanced Therapies Special Interest Group

Title of Article:"Intrapatient Comparisons Of Efficacy In A Single-Arm Trial Of Entrectinib In Tumour-Agnostic Indications"

DOI: 10.1016/j.esmoop.2021.100072

Date: July 2021

Back to Top

Title of Article:"Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients""

DOI: https://pubmed.ncbi.nlm.nih.gov/34940080/

Date: May 2022

Back to Top

Title of Article: “A review of methodological considerations for economic evaluations of gene therapies and their application in literature”

DOI: 10.1016/j.jval.2020.04.1833

Date: April 2021

Back to Top

Title of Article: “Shedding Light on Reimbursement Policies of Companion Diagnostics in European Countries”

DOI: 10.1016/j.jval.2020.01.013

Date: May 2020

Back to Top

Title of Article: Long-term Survival and Cost-effectiveness Associated with Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell Lymphoma

DOI: 10.1001/jamanetworkopen.2019.0035

Date: January 2020

Back to Top


Real World Evidence Special Interest Group

Title of Article: Use of Real- World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design

Date: June 2022

Back to Top

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×